Brain delivery of a neurotrophic peptide derived from secreted amyloid precursor protein APPsα as a therapeutic strategy for Alzheimer's disease.

RPEP-159822026Rehra, Lena; Erdinger, Susanne; Wagner, Lelia; Baltissen, Danny; Just, Jennifer; König, Leo; Mühlberg, Eric; Eisenzapf, Tom; Kilian, Lara; Banicevic, Marija; Bengelsdorff, Verena; Buchholz, Christian J; Mier, Walter; Uhl, Philipp; Korte, Martin; Fricker, Gert; Müller, Ulrike C

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Brain delivery of a neurotrophic peptide derived from secreted amyloid precursor protein APPsα as a therapeutic strategy for Alzheimer's disease.

Journal of controlled release : official journal of the Controlled Release Society, 389, 114374

View on PubMed ↗Publisher’s paper ↗

Citation

Rehra, Lena; Erdinger, Susanne; Wagner, Lelia; Baltissen, Danny; Just, Jennifer; König, Leo; Mühlberg, Eric; Eisenzapf, Tom; Kilian, Lara; Banicevic, Marija; Bengelsdorff, Verena; Buchholz, Christian J; Mier, Walter; Uhl, Philipp; Korte, Martin; Fricker, Gert; Müller, Ulrike C. (2026). Brain delivery of a neurotrophic peptide derived from secreted amyloid precursor protein APPsα as a therapeutic strategy for Alzheimer's disease.. Journal of controlled release : official journal of the Controlled Release Society, 389, 114374. https://doi.org/10.1016/j.jconrel.2025.114374